In this study, we showed that GSKJ4 protects mice against septic death and reduces the expression of inflammatory factors IL-1β, TNF-α, IL-6, and MCP-1 in vivo, suggesting that JMJD3 may be the key molecule driving early sepsis progression. Here, TNF is linked to Sepsis.